School of Medicine

Clinical trials testing treatments for neurological disorders such as Parkinson’s disease and epilepsy soon will be conducted under one roof at the School of Medicine, adding critical mass to the neuroclinical research program and convenience for patients enrolled in clinical trials.

P. Roy Vagelos, M.D., will present a lecture titled “Evolution from Basic to Translational Research (Washington University to Merck)” at noon Monday, November 29, in Cori Auditorium at Washington University School of Medicine. Vagelos was chairman of the Department of Biological Chemistry (currently the Department of Biochemistry and Molecular Biophysics) at the School of Medicine […]

Scientists at Washington University have received a five-year, $4.7 million grant from the National Cancer Institute to explore new ways to produce, distribute and use radionuclides to detect cancers.

Pain management researchers at the School of Medicine are recruiting people who have had shingles to test the effectiveness of an investigational drug designed to reduce the severe pain that can last for months or years after a bout with the disorder.

In an effort to learn about the latest research and treatments for amytrophic lateral sclerosis (ALS) and other nervous system diseases, the widow of Hans Vonk, former music director of the St. Louis Symphony Orchestra, will tour the newly established Hope Center for Neurological Disorders at the School of Medicine on Monday, Nov. 15.

Originating in Washington University research laboratories, St. Louis-based biotechnology company Apath has generated enough profit in just seven years to contribute $1 million in royalty payments back to the School of Medicine.

General asthma rates have been steadily rising, but the most dramatic increases have occurred among urban youth.

At stake are researchers’ efforts to find new ways to reduce loss of vision, kidney failure, heart damage and other diabetes side effects.

“Stated in the most basic terms, we are studying why some people are fat and some are skinny,” says lead investigator Ingrid B. Borecki.

Photo by Mary ButkusChancellor Mark S. Wrighton is presented with a plaque designating the former Cori laboratory as a National Historic Chemical Landmark.